| 注册
首页|期刊导航|肿瘤防治研究|劳拉西泮、苯海拉明、氟哌啶醇联合托烷司琼对比地塞米松联合托烷司琼预防高致吐风险化疗呕吐的疗效

劳拉西泮、苯海拉明、氟哌啶醇联合托烷司琼对比地塞米松联合托烷司琼预防高致吐风险化疗呕吐的疗效

郭秋云 于世英

肿瘤防治研究2013,Vol.40Issue(8):798-800,3.
肿瘤防治研究2013,Vol.40Issue(8):798-800,3.DOI:10.3971/j.issn.1000-8578.2013.08.017

劳拉西泮、苯海拉明、氟哌啶醇联合托烷司琼对比地塞米松联合托烷司琼预防高致吐风险化疗呕吐的疗效

Comparison of Lorazepam, Diphenhydramine, Haloperidol Combined with Tropisetron and Dexamethasone Combined with Tropisetron Efficacy in Preventing Emesis Induced by Highly Emetogenic Chemotherapy

郭秋云 1于世英1

作者信息

  • 1. 430030武汉,华中科技大学同济医学院附属同济医院肿瘤科
  • 折叠

摘要

Abstract

Objective To comparè the efficacy of lorazepam,diphenhydramine and haloperidol(abbreviation as ABH)combined with Tropisetron therapies in preventing emesis induced by highly emetogenic chemotherapy refer to 2011 edition of MASCC antiemetic guidelines.Methods One hundred and four patients treated with highly emetogenic single day chemotherapy were randomized into ABH and dexamethasone group.Both groups were given tropisetron 5mg intravenous infusion 30 minutes before chemical therapy.Patients in group ABH took lorazepam 0.34 mg,diphenhydramine 25 mg,haloperidol 1.5mg orally thrice a day on the therapy day and three days later.Group dexamethasone was given dexamethasone 20 rng once on the therapy day and 8 mg twice three days later.To study the control rate of acute,delayed nausea and vomiting and the patients living quality,we used the MASCC antiemetic questionnaires and the functional living index-Emesis questionnaire Results Fifty two patients were enrolled into each group.Both groups had a good control of acute,delayed nausea and vomiting.The control rates of acute nausea in Group ABH and Group dexamethasone were 62% vs.52%,77% vs.65% in delayed nausea,and 88% vs.87% in acute vomiting,77% vs.65% in delayed vomiting.Group ABH was better than group dexamethasone,but there was no statistical difference between them,which may be caused by the small sample sizes.It's worth mentioning that Group ABH was superior to Group dexamethasone in the control of delayed nausea degree(2.63 vs.3.69)(P<0.05).The patient's living quality was moderately influenced but there was no statistical difference and serious side effects in both groups.Conclusion Lorazepam,diphenhydramine and haloperidol (ABH)combined with 5HT-3 receptor antagonist therapy has a good effect in preventing emesis induced by highly ernetogenic chemotherapy,with little side effects,and can be to trent chemotherapy induced nausea and vomiting (CINV).

关键词

劳拉西泮/苯海拉明/氟哌啶醇/化疗相关恶心呕吐

Key words

Lorazepam/Diphenhydramine/Haloperidol/chemotherapy induced nausea and vomiting (CINV)

分类

医药卫生

引用本文复制引用

郭秋云,于世英..劳拉西泮、苯海拉明、氟哌啶醇联合托烷司琼对比地塞米松联合托烷司琼预防高致吐风险化疗呕吐的疗效[J].肿瘤防治研究,2013,40(8):798-800,3.

肿瘤防治研究

OA北大核心CSCDCSTPCD

1000-8578

访问量0
|
下载量0
段落导航相关论文